DOCSLIB.ORG

Prevalence of Paediatric Dermatoses Among Patients Attending Dermatology Outpatient Department in a Tertiary Care Hospital in Puducherry

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prevalence of Paediatric Dermatoses Among Patients Attending Dermatology Outpatient Department in a Tertiary Care Hospital in Puducherry International Journal of Research in Dermatology Medasani V et al. Int J Res Dermatol. 2018 Aug;4(3):368-375 http://www.ijord.com DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20183160 Original Research Article Prevalence of paediatric dermatoses among patients attending Dermatology outpatient department in a tertiary care hospital in Puducherry Varsha Medasani, Paquirissamy Oudeacoumar*, Rao Chitralekhya, Saurabh Krishna Misra Department of DVL, AVMC&H, Pondicherry, Puducherry, India Received: 04 April 2018 Revised: 30 May 2018 Accepted: 01 June 2018 *Correspondence: Dr. Paquirissamy Oudeacoumar, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Skin diseases are a major health problem in the paediatric age group and are associated with significant morbidity. Dermatoses in children are more influenced by socioeconomic status, dietary habits, climatic exposure and external environment as compared to adults. The present study was undertaken to know the prevalence of paediatric dermatoses among patients attending Dermatology outpatient department in a tertiary care hospital in Puducherry. Methods: All newly diagnosed, untreated male and female paediatric patients (from neonates to adolescents ≤19 years of age) attending Dermatology OPD, from October 2015 to September 2017 were evaluated to study the prevalence and patterns of paediatric dermatoses. The skin disorders were classified into groups like infections, infestations, eczemas, acne, hypersensitivity disorders, sweat gland disorders, pigmentary disorders, nevi, keratinisation disorders, hair and scalp disorders, papulosquamous disorders, bullous disorders, nail disorders, drug reactions, other dermatoses. Results: The prevalence of pediatric dermatoses in our OPD is 25.21%. Incidence of pediatric dermatoses was found to be more in males 237 (59.39%) than in females 162 (40.60%) and the majority of the patients were in adolescent age group (217; 54.38%). Present study showed that majority of cases belonged to the lower socioeconomic group 186(46.6 %). In our study, majority (58.98%) of dermatoses belonged to infections and infestations group. Of the infective dermatoses, fungal infections (27.88%) were the most common. Conclusions: Infectious dermatoses were commonly seen in this study that may be due to poverty, overcrowding, poor hygiene. There is an increasing trend of fungal infections which might be related to hygiene and environment. Keywords: Paediatric dermatoses, Children, India, Fungal infections, Bacterial infections INTRODUCTION morbidity. Thirty percent of all outpatient visits to a paediatrician includes skin diseases and 30% of all visits 2 Paediatric dermatology deals with diseases and skin care to a dermatologist involve children. Based on school- needs from birth to adolescence, during which significant based surveys, the prevalence of paediatric dermatoses in 1 physiological, psychological and maturity changes various parts of India has ranged from 8.7% to 35%. occur.1 A significant portion of paediatric dermatological disorders is of genetic origin. Majority of these disorders In paediatric age group, skin diseases are a major health 3 problem and they are associated with significant are multisystemic and persist throughout life. Factors International Journal of Research in Dermatology | July-September 2018 | Vol 4 | Issue 3 Page 368 Medasani V et al. Int J Res Dermatol. 2018 Aug;4(3):368-375 like socioeconomic status, dietary habits, climatic 4. Adolescent: 13 yrs-19 yrs exposure and external environment influences dermatoses in children as compared to adults. Cutaneous infections Informed verbal consent was taken from either of the are common in school going children. Paediatric patient’s parents before including into the study. Detailed dermatoses can be transitory or chronic and recurrent and history was taken. Thorough general, systemic and are associated with psychological impact and significant cutaneous examination and relevant investigations were morbidity.1 done. The collected data was tabulated and analysed. The present study was undertaken to know the prevalence RESULTS and patterns of paediatric dermatoses among patients attending Dermatology outpatient department in a tertiary During the study period of 2 years, 8, 472 new cases care hospital in Puducherry. attended our out-patient Department of which 2,136 belonged to paediatric age group. Thus the prevalence of METHODS paediatric dermatoses in our OPD is 25.21%. This study was conducted in Dermatology OPD of our Table 1 shows various dermatoses encountered in Institute, a tertiary care centre in Puducherry, between paediatric population. Of the 434 dermatoses encountered October 2015 and September 2017. in this study, fungal infections (27.88%) constitute majority of the dermatoses followed by bacterial Inclusion criteria infections (11.05%), viral infections (8.98%), infestations (11.05%), eczemas (11.05%), acne (8.06%), All newly diagnosed, untreated male and female hypersensitivity disorders (6.22%), sweat gland disorders paediatric patients (from neonates to adolescents ≤19 (3.68%), pigmentary disorders (1.84%), nevi (2.07%), years of age) attending Dermatology OPD. keratinisation disorders (1.84%), hair and scalp disorders (1.61%), papulosquamous disorders (0.92%), bullous Exclusion criteria disorders (0.46%), nail disorders (0.23%), drug reactions (0.23%) and other dermatoses (2.76%). Exclusion criteria were previously diagnosed and treated cases; patients not willing to consent for the study; Table 2 shows age and sex distribution of paediatric patients in whom definite diagnosis cannot be arrived at. dermatoses. In the present study 8 patients belonged to the age group <1 year, out of which 4 patients were males Methodology and four were females. Seventy six patients belonged to the age group 1-5 years, out of which 51 are males and 25 Patients were grouped according to age: are females. Ninety eight patients belong to the age group 6-12 years, out of which 60 patients are males and 38 are 1. Infant: birth to 1 yr of age females. Two hundred seventeen patients belong to the 2. Pre-school: 1-5 yrs of age age group 13-19 years, out of which 122 patients are 3. School age: 6 yrs-12 yrs males and 95 patients are females. Table 1: Various dermatoses in paediatric population. Total No of Total no of dermatoses Types of dermatoses Male Female patients (%) (N=434) (%) Fungal infections 103 (25.81) 56 47 121 (27.88) Bacterial infections 48 (12.03) 30 18 48 (11.05 ) Viral infections 39 (9.77) 24 15 39 (8.98) Infestations 48 (12.03) 38 10 48 (11.05) Eczemas 47 (11.77) 28 19 48 (11.05) Acne 35 (8.77) 17 18 35 (8.06) Hypersensitivity disorders 27 (6.76) 15 12 27 (6.22) Sweat gland disorders 16 (3.75) 9 7 16 (3.68) Pigmentary disorders 8 (2.00) 4 4 8 (1.84) Nevi 9 (2.25) 5 4 9 (2.07) Keratinisation disorders 8 (2.00) 5 2 8(1.84) Hair and scalp disorders 7 (1.75) 4 3 7 (1.61) Papulosquamous disorders 4 (1.00) 3 1 4 (0.92) Bullous disorders 2 (0.50) 0 2 2 (0.46) Nail disorders 1 (0.25) 0 1 1 (0.23) Drug reactions 1 (0.25) 1 0 1 (0.23) Other dermatoses 12 (3.00) 6 6 12 (2.76) International Journal of Research in Dermatology | July-September 2018 | Vol 4 | Issue 3 Page 369 Medasani V et al. Int J Res Dermatol. 2018 Aug;4(3):368-375 Table 2: Age and sex distribution of paediatric dermatoses. Age (in years) Male Female Total <1 4 4 8 1-5 51 25 76 6-12 60 38 98 13-19 122 95 217 Total 237 162 399 Table 3: Infections & infestations. Infections Infestations Total dermatoses (%) Male Female Pityriasis versicolor 33 (27.27) 16 17 Candidial Intertrigo 4 (3.30) 1 3 T. corporis 36 (29.75) 21 15 T. cruris 41 (33.88) 25 16 Fungal infections T. incognito 4 (3.30) 2 2 T. facieii 2 (1.65) 1 1 Candidial balanoposthitis 1 (0.82) 1 0 Total 121 (100) 67 (55.37%) 54 (44.62%) Impetigo 37 (77.08) 23 14 Folliculitis 6 (12.5) 4 2 Furunculosis 2 (4.16) 0 2 Bacterial infections Pitted keratolysis 1 (2.08) 1 0 Lupus vulgaris 1 (2.08) 1 0 Lepromatous leprosy 1 (2.08) 1 0 Total 48 (100) 30 (62.5%) 18 (37.5%) Chicken pox 2 (5.12) 1 1 Herpes zoster 1 (2.56) 0 1 Molluscum contagiosum 8 (20.51) 6 2 HFMD 2 (5.12) 1 1 Pityriasis rosea 5 (12.82) 4 1 Papular acrodermatitis 1 (2.56) 1 0 Viral infections Verruca vulgaris 14 (35.89) 7 7 Digitate wart 1 (2.56) 1 0 Plane wart 1 (2.56) 1 0 Palmar wart 2 (5.12) 1 1 Plantar wart 2 (5.12) 1 1 Total 39 (100) 24 (61.5%) 15 (38.46%) Scabies 45 (93.75) 38 7 Infestations Pediculosis 3 (6.25) 0 3 Total 48 (100) 38 (79.16%) 10 (20.83%) Table 3 shows various infections and infestations atopic dermatitis in 11 (22.91%) patients, seborrhoeic encountered in this study. Fungal infections (27.81%) dermatitis in 8 (16.66%), subacute eczema in 3 (6.25%), were the commonest infections in this study followed by keratosis pilaris in 3 (6.25%), chronic eczema in 1 bacterial infections (12.03%) and viral infections (2.08%), pompholyx in 1 (2.08%), nipple eczema in 1 (9.77%). Scabies was the most common infestation seen (2.08%), infective eczema in 1 (2.08%), infected eczema in 45 patients (93.75%). Pediculosis is seen in 3 female in 1 (2.08%), allergic contact dermatitis in 1 (2.08%), and patients (6.25%) only.
Load more

Recommended publications
  • Dermatology DDX Deck, 2Nd Edition 65
    63. Herpes simplex (cold sores, fever blisters) PREMALIGNANT AND MALIGNANT NON- 64. Varicella (chicken pox) MELANOMA SKIN TUMORS Dermatology DDX Deck, 2nd Edition 65. Herpes zoster (shingles) 126. Basal cell carcinoma 66. Hand, foot, and mouth disease 127. Actinic keratosis TOPICAL THERAPY 128. Squamous cell carcinoma 1. Basic principles of treatment FUNGAL INFECTIONS 129. Bowen disease 2. Topical corticosteroids 67. Candidiasis (moniliasis) 130. Leukoplakia 68. Candidal balanitis 131. Cutaneous T-cell lymphoma ECZEMA 69. Candidiasis (diaper dermatitis) 132. Paget disease of the breast 3. Acute eczematous inflammation 70. Candidiasis of large skin folds (candidal 133. Extramammary Paget disease 4. Rhus dermatitis (poison ivy, poison oak, intertrigo) 134. Cutaneous metastasis poison sumac) 71. Tinea versicolor 5. Subacute eczematous inflammation 72. Tinea of the nails NEVI AND MALIGNANT MELANOMA 6. Chronic eczematous inflammation 73. Angular cheilitis 135. Nevi, melanocytic nevi, moles 7. Lichen simplex chronicus 74. Cutaneous fungal infections (tinea) 136. Atypical mole syndrome (dysplastic nevus 8. Hand eczema 75. Tinea of the foot syndrome) 9. Asteatotic eczema 76. Tinea of the groin 137. Malignant melanoma, lentigo maligna 10. Chapped, fissured feet 77. Tinea of the body 138. Melanoma mimics 11. Allergic contact dermatitis 78. Tinea of the hand 139. Congenital melanocytic nevi 12. Irritant contact dermatitis 79. Tinea incognito 13. Fingertip eczema 80. Tinea of the scalp VASCULAR TUMORS AND MALFORMATIONS 14. Keratolysis exfoliativa 81. Tinea of the beard 140. Hemangiomas of infancy 15. Nummular eczema 141. Vascular malformations 16. Pompholyx EXANTHEMS AND DRUG REACTIONS 142. Cherry angioma 17. Prurigo nodularis 82. Non-specific viral rash 143. Angiokeratoma 18. Stasis dermatitis 83.
    [Show full text]
  • Pattern of Pediatric Dermatoses in a Tertiary Care Centre in Karnataka
    Original Research Article Pattern of Pediatric Dermatoses in a Tertiary Care Centre in Karnataka Bangaru H1,*, Nanjundaswamy BL2 1Assistant Professor, 2Professor, Mysore Medical College & Research Institute, Mysore *Corresponding Author: Email: [email protected] Abstract Background: Skin diseases are major health problem in the pediatric age group and it reflects the status of health, nutrition, hygiene and personal cleanliness of a community. Objective: 1. To estimate the proportion of pediatric skin diseases. 2. To estimate and test the impact of age and sex on pediatric skin diseases 3. To prioritize the condition of skin diseases among pediatric age group. Inclusion criteria: All cases registered in outpatient records aged 0-18 years. Exclusion criteria: None. Materials and Methods: Study design: Retrospective study. Retrospective collection of data from the out patient records, of all children aged 0-18 years, who had attended as out-patient, in dermatology out-patient department, in Krishna Rajendra Hospital, Mysore, Karnataka. The diseases will be tabulated based on age, sex and etiology and results will be analysed. Sample size: With the incidence of pediatric dermatoses 9-37%, level of significance 5%, absolute allowable error 5%, using confidence interval approach, the sample size is 131-373. However, over a period of six months, 3753 pediatric case sheets have been considered for the study. Statistical method: Objective 1 is analysed through frequency and proportion, objective 2 is analysed through bivariate frequency technique using frequency, chi-square test and object 3 is addressed through frequency technique. Results: Out of 16500 out patients 3753 were children aged 0-18 years. Males (1984) were slightly more than females (1769) with male to female ratio of 1.12:1.
    [Show full text]
  • COVID-19 Mrna Pfizer- Biontech Vaccine Analysis Print
    COVID-19 mRNA Pfizer- BioNTech Vaccine Analysis Print All UK spontaneous reports received between 9/12/20 and 22/09/21 for mRNA Pfizer/BioNTech vaccine. A report of a suspected ADR to the Yellow Card scheme does not necessarily mean that it was caused by the vaccine, only that the reporter has a suspicion it may have. Underlying or previously undiagnosed illness unrelated to vaccination can also be factors in such reports. The relative number and nature of reports should therefore not be used to compare the safety of the different vaccines. All reports are kept under continual review in order to identify possible new risks. Report Run Date: 24-Sep-2021, Page 1 Case Series Drug Analysis Print Name: COVID-19 mRNA Pfizer- BioNTech vaccine analysis print Report Run Date: 24-Sep-2021 Data Lock Date: 22-Sep-2021 18:30:09 MedDRA Version: MedDRA 24.0 Reaction Name Total Fatal Blood disorders Anaemia deficiencies Anaemia folate deficiency 1 0 Anaemia vitamin B12 deficiency 2 0 Deficiency anaemia 1 0 Iron deficiency anaemia 6 0 Anaemias NEC Anaemia 97 0 Anaemia macrocytic 1 0 Anaemia megaloblastic 1 0 Autoimmune anaemia 2 0 Blood loss anaemia 1 0 Microcytic anaemia 1 0 Anaemias haemolytic NEC Coombs negative haemolytic anaemia 1 0 Haemolytic anaemia 6 0 Anaemias haemolytic immune Autoimmune haemolytic anaemia 9 0 Anaemias haemolytic mechanical factor Microangiopathic haemolytic anaemia 1 0 Bleeding tendencies Haemorrhagic diathesis 1 0 Increased tendency to bruise 35 0 Spontaneous haematoma 2 0 Coagulation factor deficiencies Acquired haemophilia
    [Show full text]
  • Therapies for Common Cutaneous Fungal Infections
    MedicineToday 2014; 15(6): 35-47 PEER REVIEWED FEATURE 2 CPD POINTS Therapies for common cutaneous fungal infections KENG-EE THAI MB BS(Hons), BMedSci(Hons), FACD Key points A practical approach to the diagnosis and treatment of common fungal • Fungal infection should infections of the skin and hair is provided. Topical antifungal therapies always be in the differential are effective and usually used as first-line therapy, with oral antifungals diagnosis of any scaly rash. being saved for recalcitrant infections. Treatment should be for several • Topical antifungal agents are typically adequate treatment weeks at least. for simple tinea. • Oral antifungal therapy may inea and yeast infections are among the dermatophytoses (tinea) and yeast infections be required for extensive most common diagnoses found in general and their differential diagnoses and treatments disease, fungal folliculitis and practice and dermatology. Although are then discussed (Table). tinea involving the face, hair- antifungal therapies are effective in these bearing areas, palms and T infections, an accurate diagnosis is required to ANTIFUNGAL THERAPIES soles. avoid misuse of these or other topical agents. Topical antifungal preparations are the most • Tinea should be suspected if Furthermore, subsequent active prevention is commonly prescribed agents for dermatomy- there is unilateral hand just as important as the initial treatment of the coses, with systemic agents being used for dermatitis and rash on both fungal infection. complex, widespread tinea or when topical agents feet – ‘one hand and two feet’ This article provides a practical approach fail for tinea or yeast infections. The pharmacol- involvement. to antifungal therapy for common fungal infec- ogy of the systemic agents is discussed first here.
    [Show full text]
  • Copyrighted Material
    Part 1 General Dermatology GENERAL DERMATOLOGY COPYRIGHTED MATERIAL Handbook of Dermatology: A Practical Manual, Second Edition. Margaret W. Mann and Daniel L. Popkin. © 2020 John Wiley & Sons Ltd. Published 2020 by John Wiley & Sons Ltd. 0004285348.INDD 1 7/31/2019 6:12:02 PM 0004285348.INDD 2 7/31/2019 6:12:02 PM COMMON WORK-UPS, SIGNS, AND MANAGEMENT Dermatologic Differential Algorithm Courtesy of Dr. Neel Patel 1. Is it a rash or growth? AND MANAGEMENT 2. If it is a rash, is it mainly epidermal, dermal, subcutaneous, or a combination? 3. If the rash is epidermal or a combination, try to define the SIGNS, COMMON WORK-UPS, characteristics of the rash. Is it mainly papulosquamous? Papulopustular? Blistering? After defining the characteristics, then think about causes of that type of rash: CITES MVA PITA: Congenital, Infections, Tumor, Endocrinologic, Solar related, Metabolic, Vascular, Allergic, Psychiatric, Latrogenic, Trauma, Autoimmune. When generating the differential, take the history and location of the rash into account. 4. If the rash is dermal or subcutaneous, then think of cells and substances that infiltrate and associated diseases (histiocytes, lymphocytes, mast cells, neutrophils, metastatic tumors, mucin, amyloid, immunoglobulin, etc.). 5. If the lesion is a growth, is it benign or malignant in appearance? Think of cells in the skin and their associated diseases (keratinocytes, fibroblasts, neurons, adipocytes, melanocytes, histiocytes, pericytes, endothelial cells, smooth muscle cells, follicular cells, sebocytes, eccrine
    [Show full text]
  • University of Groningen Hand Eczema Christoffers, Wianda
    University of Groningen Hand eczema Christoffers, Wianda IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2014 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Christoffers, W. (2014). Hand eczema: interventions & contact allergies. [S.n.]. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 10-10-2021 Hand eczema interventions and contact allergies Wietske Andrea Christoffers ISBN: 978-90-367-7355-3 (printed version) ISBN: 978-90-367-7354-6 (e-version) © W.A.
    [Show full text]
  • Statistical Analysis Plan
    Cover Page for Statistical Analysis Plan Sponsor name: Novo Nordisk A/S NCT number NCT03061214 Sponsor trial ID: NN9535-4114 Official title of study: SUSTAINTM CHINA - Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Document date: 22 August 2019 Semaglutide s.c (Ozempic®) Date: 22 August 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL Clinical Trial Report Status: Final Appendix 16.1.9 16.1.9 Documentation of statistical methods List of contents Statistical analysis plan...................................................................................................................... /LQN Statistical documentation................................................................................................................... /LQN Redacted VWDWLVWLFDODQDO\VLVSODQ Includes redaction of personal identifiable information only. Statistical Analysis Plan Date: 28 May 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL UTN:U1111-1149-0432 Status: Final EudraCT No.:NA Page: 1 of 30 Statistical Analysis Plan Trial ID: NN9535-4114 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Author Biostatistics Semaglutide s.c. This confidential document is the property of Novo Nordisk. No unpublished information contained herein may be disclosed without prior written approval from Novo Nordisk. Access to this document must be restricted to relevant parties.This
    [Show full text]
  • ACNE 1743 Review ISOTR Adverse Effects
    Australasian Journal of Dermatology (2010) 51, 248–253 doi: 10.1111/j.1440-0960.2010.00657.x ORIGINAL ARTICLE Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoinajd_657 248..253 Marius Rademaker Tristram Clinic, Hamilton, New Zealand eczema (6) and pregnancy (2). There were no reported ABSTRACT instances of suicidal ideation or attempted suicide. Background/Objectives: Isotretinoin has revolu- Conclusions: Other than the two oral contraceptive tionized the management of acne vulgaris. However, failures, there were no serious adverse events concerns continue regarding the adverse effect recorded during this review period. Isotretinoin is a profile of isotretinoin. This study aims to review the very effective medication with a low adverse-effect adverse effects experienced by patients started on profile when used at lower doses. isotretinoin by a single dermatologist. Key words: acne vulgaris, depression, side-effect, Methods: Retrospective chart review of 1743 teratogenicity. patients started on isotretinoin for various dermato- logical conditions over a 6-year period. Details of the dose of isotretinoin used, concomitant medications, INTRODUCTION adverse effects and outcome were recorded. Isotretinoin (13-cis-retinoic acid) revolutionized the man- Results: One-fifth (18.5%) of patients reported no agement of acne vulgaris and various other skin disorders adverse effects during the study period. Cheilitis was when it was introduced in the 1980s.1,2 Isotretinoin was the the most commonly reported adverse effect, affecting first medication to modify the disease, rather than provide 78% of users, followed by eczema and tiredness, seen symptom control. In the last decade, it is estimated that in 12% each.
    [Show full text]
  • A Deep Learning System for Differential Diagnosis of Skin Diseases
    A deep learning system for differential diagnosis of skin diseases 1 1 1 1 1 1,2 † Yuan Liu ,​ Ayush Jain ,​ Clara Eng ,​ David H. Way ,​ Kang Lee ,​ Peggy Bui ,​ Kimberly Kanada ,​ ​ ​ ‡ ​ 1​ ​ 1 ​ 1 ​ Guilherme de Oliveira Marinho ,​ Jessica Gallegos ,​ Sara Gabriele ,​ Vishakha Gupta ,​ Nalini 1,3,§ 1 ​ ​ 4 ​ 1 ​ ​ 1 Singh ,​ Vivek Natarajan ,​ Rainer Hofmann-Wellenhof ,​ Greg S. Corrado ,​ Lily H. Peng ,​ Dale ​ ​ 1 1 ​ † 1, ​ 1, ​ 1, ​ R. Webster ,​ Dennis Ai ,​ Susan Huang ,​ Yun Liu *​ , R. Carter Dunn *​ *, David Coz *​ * ​ ​ ​ ​ ​ ​ Affiliations: 1 G​ oogle Health, Palo Alto, CA, USA 2 U​ niversity of California, San Francisco, CA, USA 3 M​ assachusetts Institute of Technology, Cambridge, MA, USA 4 M​ edical University of Graz, Graz, Austria † W​ ork done at Google Health via Advanced Clinical. ‡ W​ ork done at Google Health via Adecco Staffing. § W​ ork done at Google Health. *Corresponding author: [email protected] **These authors contributed equally to this work. Abstract Skin and subcutaneous conditions affect an estimated 1.9 billion people at any given time and remain the fourth leading cause of non-fatal disease burden worldwide. Access to dermatology care is limited due to a shortage of dermatologists, causing long wait times and leading patients to seek dermatologic care from general practitioners. However, the diagnostic accuracy of general practitioners has been reported to be only 0.24-0.70 (compared to 0.77-0.96 for dermatologists), resulting in over- and ​ ​ ​ ​ ​ ​ ​ under-referrals, delays in care, and errors in diagnosis and treatment. In this paper, we developed a deep learning system (DLS) to provide a differential diagnosis of skin conditions for clinical cases (skin photographs and associated medical histories).
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,359,748 B1 Drugge (45) Date of Patent: Apr
    USOO7359748B1 (12) United States Patent (10) Patent No.: US 7,359,748 B1 Drugge (45) Date of Patent: Apr. 15, 2008 (54) APPARATUS FOR TOTAL IMMERSION 6,339,216 B1* 1/2002 Wake ..................... 250,214. A PHOTOGRAPHY 6,397,091 B2 * 5/2002 Diab et al. .................. 600,323 6,556,858 B1 * 4/2003 Zeman ............. ... 600,473 (76) Inventor: Rhett Drugge, 50 Glenbrook Rd., Suite 6,597,941 B2. T/2003 Fontenot et al. ............ 600/473 1C, Stamford, NH (US) 06902-2914 7,092,014 B1 8/2006 Li et al. .................. 348.218.1 (*) Notice: Subject to any disclaimer, the term of this k cited. by examiner patent is extended or adjusted under 35 Primary Examiner Daniel Robinson U.S.C. 154(b) by 802 days. (74) Attorney, Agent, or Firm—McCarter & English, LLP (21) Appl. No.: 09/625,712 (57) ABSTRACT (22) Filed: Jul. 26, 2000 Total Immersion Photography (TIP) is disclosed, preferably for the use of screening for various medical and cosmetic (51) Int. Cl. conditions. TIP, in a preferred embodiment, comprises an A6 IB 6/00 (2006.01) enclosed structure that may be sized in accordance with an (52) U.S. Cl. ....................................... 600/476; 600/477 entire person, or individual body parts. Disposed therein are (58) Field of Classification Search ................ 600/476, a plurality of imaging means which may gather a variety of 600/162,407, 477, 478,479, 480; A61 B 6/00 information, e.g., chemical, light, temperature, etc. In a See application file for complete search history. preferred embodiment, a computer and plurality of USB (56) References Cited hubs are used to remotely operate and control digital cam eras.
    [Show full text]
  • Mallory Prelims 27/1/05 1:16 Pm Page I
    Mallory Prelims 27/1/05 1:16 pm Page i Illustrated Manual of Pediatric Dermatology Mallory Prelims 27/1/05 1:16 pm Page ii Mallory Prelims 27/1/05 1:16 pm Page iii Illustrated Manual of Pediatric Dermatology Diagnosis and Management Susan Bayliss Mallory MD Professor of Internal Medicine/Division of Dermatology and Department of Pediatrics Washington University School of Medicine Director, Pediatric Dermatology St. Louis Children’s Hospital St. Louis, Missouri, USA Alanna Bree MD St. Louis University Director, Pediatric Dermatology Cardinal Glennon Children’s Hospital St. Louis, Missouri, USA Peggy Chern MD Department of Internal Medicine/Division of Dermatology and Department of Pediatrics Washington University School of Medicine St. Louis, Missouri, USA Mallory Prelims 27/1/05 1:16 pm Page iv © 2005 Taylor & Francis, an imprint of the Taylor & Francis Group First published in the United Kingdom in 2005 by Taylor & Francis, an imprint of the Taylor & Francis Group, 2 Park Square, Milton Park Abingdon, Oxon OX14 4RN, UK Tel: +44 (0) 20 7017 6000 Fax: +44 (0) 20 7017 6699 Website: www.tandf.co.uk All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the publisher or in accordance with the provisions of the Copyright, Designs and Patents Act 1988 or under the terms of any licence permitting limited copying issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1P 0LP. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention.
    [Show full text]
  • Unmasking the Mask: COVID-19 Manifestations of PPE Kits
    Our Dermatology Online Review Article UUnmaskingnmasking tthehe mmask:ask: CCOVID-19OVID-19 manifestationsmanifestations ooff PPPEPE kkitsits Santhanakrishnaan Soundarya, Srinivasan Sundaramoorthy Department of Dermatology, Chettinad Hospital and Research Institute, Kelambakkam, Tamil Nadu, India Corresponding author: Prof. Srinivasan Sundaramoorthy, MD PhD, E-mail: [email protected] ABSTRACT The world is now facing a new unexpected pandemic caused by SARS-CoV-2, which is a coronavirus that mainly targets the lungs, a very vital and sensitive organ of the body. Research and healthcare workers are still struggling to contain the disease and eradicate the virus. Before the invention of a vaccine, the virus may take at least several more millions of lives. On top of this, dermatologists are facing numerous challenges because of the regulations put forward by the WHO and local governments. This article discusses in detail various dermatological eruptions caused by the personal protective equipment (PPE) used in combating the disease. This should be an eye-opener for dermatologists worldwide. Key words: COVID-19; Pandemic; PPE kits; Masks INTRODUCTION chemical), immunological regulation, thermoregulation, sensory function, synthesis of vitamin D, wound repair, The COVID-19 pandemic, caused by the virus named and regeneration and is, above all, regarded as an organ SARS-CoV-2, was first reported in Wuhan, China, in of beauty. 2019, and then rapidly spread to more than 200 countries across the globe [1]. Its transmission mainly occurs This largest organ of the body harbors an ecosystem through droplets and aerosols spread by an affected of microorganisms (commensals) (Table 1). These person, whether symptomatic or asymptomatic, but organisms live in harmony with the host without the former being more contagious than the latter [2,3].
    [Show full text]